A team of researchers has linked caffeine consumption with a lower risk of type 2 diabetes and with reduced weight and fat mass.
The results have been contributed by an international team of researchers led by Susana Larsson, from the Institute of Environmental Medicine of the University of Stockholm (Sweden), and their conclusions have been published in the British Medical Journal.
The study sought to understand the casual effects of long-term blood caffeine concentrations on adiposity, type 2 diabetes, and major cardiovascular diseases, and to do so they focused on analyzes of total body mass index, type 2 diabetes 2, ischemic heart disease, atrial fibrillation, heart failure and cardiovascular accidents.
And the results have come to the conclusion that higher caffeine concentrations are associated with lower body mass index and fat mass, as well as a lower risk of type 2 diabetes.
The data from the study have suggested that approximately half of the effect of caffeine in type 2 diabetes is mediated by the reduction in body mass index, although researchers have emphasized the importance of conducting long-term clinical studies.
Until now, some studies had already shown that caffeine intake results in a reduction in weight and fat mass and that coffee consumption was also related to a lower risk of type 2 diabetes and cardiovascular disease.
